These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 17707197

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of dose distributions around the pulsed-dose-rate Fletcher-Williamson and the low-dose-rate Fletcher-Suit-Delclos ovoids: a Monte Carlo study.
    Price MJ, Gifford KA, Horton J, Lawyer A, Eifel P, Mourtada F.
    Phys Med Biol; 2006 Aug 21; 51(16):4083-94. PubMed ID: 16885626
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
    Noyes WR, Peters NE, Thomadsen BR, Fowler JF, Buchler DA, Stitt JA, Kinsella TJ.
    Int J Radiat Oncol Biol Phys; 1995 Jan 01; 31(1):79-86. PubMed ID: 7995771
    [Abstract] [Full Text] [Related]

  • 8. A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model.
    Hsu IC, Speight J, Hai J, Vigneault E, Phillips T, Pouliot J.
    Int J Radiat Oncol Biol Phys; 2002 Feb 01; 52(2):538-43. PubMed ID: 11872302
    [Abstract] [Full Text] [Related]

  • 9. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson MT, Yuen J, D'Souza DP, Batchelar DL.
    Brachytherapy; 2008 Feb 01; 7(1):37-42. PubMed ID: 18299111
    [Abstract] [Full Text] [Related]

  • 10. Dosimetric comparison of tandem and Ovoids vs. tandem and ring for intracavitary gynecologic applications.
    Levin D, Menhel J, Rabin T, Pfeffer MR, Symon Z.
    Med Dosim; 2008 Feb 01; 33(4):315-20. PubMed ID: 18973861
    [Abstract] [Full Text] [Related]

  • 11. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer.
    Chajon E, Dumas I, Touleimat M, Magné N, Coulot J, Verstraet R, Lefkopoulos D, Haie-Meder C.
    Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):955-61. PubMed ID: 17889277
    [Abstract] [Full Text] [Related]

  • 12. Use of the rectal retractor to reduce the rectal dose in high dose rate intracavitary brachytherapy for a carcinoma of the uterine cervix.
    Lee KC, Kim TH, Choi JH, Choi MS, Kim CY, Kim JY.
    Yonsei Med J; 2004 Feb 29; 45(1):113-22. PubMed ID: 15004877
    [Abstract] [Full Text] [Related]

  • 13. [Optimization of dose distribution in combined irradiation of uterine cervix cancer with gamma-ray cesium-137 and X-9 MeV].
    Lewocki M.
    Ann Acad Med Stetin; 1996 Feb 29; 42():199-222. PubMed ID: 9199121
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of dose distributions of HDR intracavitary brachytherapy using different sources and treatment planning systems.
    Park DW, Kim YS, Park SH, Choi EK, Ahn SD, Lee SW, Song SY, Kim JH.
    Appl Radiat Isot; 2009 Feb 29; 67(7-8):1426-31. PubMed ID: 19307128
    [Abstract] [Full Text] [Related]

  • 16. A quantitative three-dimensional dose attenuation analysis around Fletcher-Suit-Delclos due to stainless steel tube for high-dose-rate brachytherapy by Monte Carlo calculations.
    Parsai EI, Zhang Z, Feldmeier JJ.
    Brachytherapy; 2009 Feb 29; 8(3):318-23. PubMed ID: 19217355
    [Abstract] [Full Text] [Related]

  • 17. Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry.
    Tanderup K, Christensen JJ, Granfeldt J, Lindegaard JC.
    Radiother Oncol; 2006 Apr 29; 79(1):87-93. PubMed ID: 16546281
    [Abstract] [Full Text] [Related]

  • 18. Comparison of late toxicity between continuous low-dose-rate and pulsed-dose-rate brachytherapy in cervical cancer patients.
    Bachtiary B, Dewitt A, Pintilie M, Jezioranski J, Ahonen S, Levin W, Manchul L, Yeung I, Milosevic M, Fyles A.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1077-82. PubMed ID: 16024181
    [Abstract] [Full Text] [Related]

  • 19. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
    Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J.
    Int J Radiat Oncol Biol Phys; 2008 Jul 01; 71(3):756-64. PubMed ID: 18191335
    [Abstract] [Full Text] [Related]

  • 20. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS, Sohn DK, Kim JY, Kim JW, Shin KH, Yoon SM, Kim DY, Yoon M, Shin D, Park SY, Cho KH.
    Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1446-54. PubMed ID: 17482766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.